Drugs / Bromonide
last change Jan 2019 re-read 3 minutes ago

Bromonide

Developed for
rosacea

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT03053700 Comparator Dec 2018 → Jan 2019 rosacea Rabin Medical Center Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bromonide ClinicalTrials.gov intervention name — accepted as the source's own label NCT03053700 ↗
Route Topical “full face application of bromonide 0.33% gel” NCT03053700 ↗